830
Participants
Start Date
June 30, 2013
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
EVP-6124
Arm 1, 2
Little Rock
Anaheim
Bellflower
Cerritos
Chino
Costa Mesa
Culver City
Downey
Escondido
Garden Grove
Glendale
Los Angeles
Mesa
Norwalk
Oakland
Oceanside
Orange
Riverside
San Diego
San Gabriel
Santa Ana
Sherman Oaks
Torrance
Washington D.C.
Lauderhill
Miami
Miami Springs
North Miami
Oakland Park
Orange City
Orlando
Atlanta
Marietta
Smyrna
Chicago
Oak Brook
Oak Park
Wichita
Lake Charles
Shreveport
Boston
Minneapolis
Flowood
Creve Coeur
O'Fallon
Saint Charles
St Louis
Lincoln
Omaha
Nashua
Princeton
Albuquerque
Cedarhurst
Jamaica
New York
Charlotte
Cleveland
Shaker Hts.
Oklahoma City
Conshohocken
Jenkintown
Norristown
Philadelphia
Phoenixville
Austin
Dallas
Salt Lake City
Bellevue
Spokane
La Plata
Mendoza
C.a.b.a
Adelaide
Melbourne
Mechelen
Calgary
Penticton
Chatham
Kingston
Montreal
Medellín
Barranquilla
Pereira
Bogota D.C.
Bogota D.C
Berlin
Düsseldorf
Leipzig
Mittweida
Stralsund
Catania
Milan
Roma
Guadalajara
Mexico City
Monterrey
San Luis Potosí City
Mexico City
Bełchatów
Campulung Muscel
Oradea
Cluj-Napacu
Cluj-Napoca
Palazu Mare
Târgu Mureş
Bucharest
Talagi
Smolensk
Moscow
Saint Petersburg
Stavropol
Yaroslavl
Singapore
Salamanca
Zamora
Alcorcón
Coslada
Madrid
Vil. Stepanivka
Dnipropetrovsk
Ivano-Frankivsk
Kharkiv
Kyiv
Lviv
Poltara
Poltava
Vinnytsia
London
Lead Sponsor
Collaborators (1)
Syneos Health
OTHER
FORUM Pharmaceuticals Inc
INDUSTRY